AIP
VERA icon

Ameritas Investment Partners’s Vera Therapeutics VERA Stock Holding History

Ameritas Investment Partners’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$204K Buy
5,061
+549
+12% +$23.7K 0.01% 1251
2025
Q4 		$228K Buy
4,512
+213
+5% +$7.57K 0.01% 1176
2025
Q3 		$125K Sell
4,299
-955
-18% -$22.1K ﹤0.01% 1544
2025
Q2 		$124K Buy
5,254
+615
+13% +$13.8K ﹤0.01% 1605
2025
Q1 		$111K Hold
4,639
– – ﹤0.01% 1631
2024
Q4 		$196K Buy
4,639
+639
+16% +$28.3K 0.01% 1334
2024
Q3 		$177K Hold
4,000
– – 0.01% 1400
2024
Q2 		$145K Hold
4,000
– – 0.01% 1485
2024
Q1 		$172K Buy
4,000
+688
+21% +$24.5K 0.01% 1386
2023
Q4 		$50.9K Hold
3,312
– – ﹤0.01% 2164
2023
Q3 		$45.4K Buy
3,312
+520
+19% +$8.92K ﹤0.01% 2162
2023
Q2 		$44.8K Buy
2,792
+1,731
+163% +$15.6K ﹤0.01% 2116
2023
Q1 		$8.23K Hold
1,061
– – ﹤0.01% 2779
2022
Q4 		$9.69K Hold
1,061
– – ﹤0.01% 2814
2022
Q3 		$22K Hold
1,061
– – ﹤0.01% 2491
2022
Q2 		$14K Hold
1,061
– – ﹤0.01% 2724
2022
Q1 		$25K Buy
1,061
+519
+96% +$11.2K ﹤0.01% 2466
2021
Q4 		$14K Hold
542
– – ﹤0.01% 2799
2021
Q3 		$9K Buy
+542
New +$9.69K ﹤0.01% 2973

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameritas Investment Partners's VERA Position: Q1 2026 in Review

Ameritas Investment Partners increased its Vera Therapeutics (VERA) stake by 12% in Q1 2026, buying an estimated $23.7K and bringing the position to 5,061 shares worth $204K. The position accounts for 0.01% of the portfolio, ranked #1251.

Ameritas Investment Partners first reported a position in VERA in Q3 2021 and has held it in 19 quarters since. The position peaked at $228K in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Ameritas Investment Partners held 5,061 shares of Vera Therapeutics worth $204K as of Q1 2026.
  • Ameritas Investment Partners bought 549 Vera Therapeutics shares in Q1 2026, an estimated $23.7K.
  • Vera Therapeutics made up 0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #1251 holding.
  • Ameritas Investment Partners first reported a position in Vera Therapeutics in Q3 2021 and has held it in 19 quarters since.
  • Ameritas Investment Partners's Vera Therapeutics position peaked at $228K in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.